Nobiletin Prevents Body Weight Gain and Bone Loss in Ovariectomized C57BL/6J Mice

Lee, Young-Sil and Asai, Midori and Choi, Sun-Sil and Yonezawa, Takayuki and Teruya, Toshiaki and Nagai, Kazuo and Woo, Je-Tae and Cha, Byung-Yoon (2014) Nobiletin Prevents Body Weight Gain and Bone Loss in Ovariectomized C57BL/6J Mice. Pharmacology & Pharmacy, 05 (10). pp. 959-965. ISSN 2157-9423

[thumbnail of PP_2014092415534422.pdf] Text
PP_2014092415534422.pdf - Published Version

Download (3MB)

Abstract

Obesity and osteoporosis are associated with estrogen deficiency following menopause. Therefore, it is important to prevent and treat both disorders to maintain a healthy life in postmenopausal women. Nobiletin, a polymethoxylated flavone, exhibits various pharmacologic effects, including anti-tumor and anti-inflammatory activities. Therefore, in this study, we examined the effects of nobiletin on obesity, obesity-related metabolic disorders, and bone mass in ovariectomized (OVX) mice. Mice were divided into four groups and underwent sham operation or OVX. OVX mice were treated with 50 or 100 mg/kg nobiletin, or received vehicle alone (0.3% carboxyl methyl cellulose/0.5% dimethyl sulfoxide). Nobiletin decreased body weight gain and white adipose tissue weight in OVX mice. Nobiletin also decreased triglyceride levels, and tended to reduce plasma total cholesterol and glucose levels. Additionally, nobiletin prevented the reduction in bone mineral density of the trabecular region of the femur in OVX mice. Taken together, our results suggest that nobiletin improves adiposity, dyslipidemia, hyperglycemia, and prevents bone loss in OVX mice. Therefore, nobiletin is expected to have beneficial effects for the prevention and improvement of metabolic disorders and osteoporosis in postmenopausal women.

Item Type: Article
Subjects: OA Digital Library > Chemical Science
Depositing User: Unnamed user with email support@oadigitallib.org
Date Deposited: 21 Feb 2023 07:43
Last Modified: 17 Jun 2024 06:23
URI: http://library.thepustakas.com/id/eprint/531

Actions (login required)

View Item
View Item